Don't Say That Word | home 
Cancer Gene - "Double Whammy"
By Gabe Romain, Betterhumans Staff
A "double whammy" genetic mechanism has been discovered that inhibits DNA repair and prevents the destruction of DNA-damaged cells, both of which can cause cancer.
The discovery, by scientists at the Babraham Institute in Cambridge, UK could lead to new cancer treatments.
The gene inhibits the repair of DNA damage that often occurs as cells divide, allowing damage to quickly accumulate.
It also prevents cells with damaged DNA from being eliminated, leading to cancer.
"It is quite likely that if only one of these mechanisms were taking place, there would be no cancer," says researcher Denis Alexander. "It's when both occur simultaneously, the 'double whammy,' that the catastrophe happens."
Affects cell protector
The researchers focused on a protein called Bcl-xL that normally keeps cells from dying.
When DNA in cells becomes damaged, the protein is modified in such a way that it no longer keeps cells alive.
Cells with damaged DNA therefore die, preventing them from becoming cancerous.
But in the presence of a particular cancer gene, the researchers found, the usual modification doesn't occur, and cells with damaged DNA stay alive and become cancerous.
The researchers made the discovery by examining changes in Bcl-xL that normally occur after cells are exposed to radiation.
Looking at mice with a cancer-causing version of an enzyme called tyrosine kinase, they found that the changes didn't happen.
"The cancer model that we're working on is T cell lymphomas," says researcher Denis Alexander. "But it's quite likely that this mechanism could be relevant to other types of cancer as well."
New treatments
Understanding the intricacies of the mechanism, such as how the cancer gets going in the first place, might eventually lead to new cancer treatments.
The researchers have also shown that the Bcl-xL's cell-killing ablities remain blocked in tumors even when they've been exposed to reagents used in chemotherapy.
"If we could find a way of averting this blockade, then the power of Bcl-xL in keeping tumor cells alive would be destroyed, and the tumor would either spontaneously die or would at least become more sensitive to chemotherapy or radiotherapy," says Alexander.
|